Concord Biotech shareholding pattern

CONCORDBIO

HealthcareLarge

1642.5

8.90 (0.54%)
Last updated on 14 Aug, 2025 | 15:40 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Concord Biotech Shareholding Pattern

  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

44.08%

Mutual Fund

4.68%

Insurance

3.41%

Foreign Institutional Investors

9.1%

Domestic Institutional Investors

0.76%

Retail

37.96%

Others

0.01%

Total Promoters
MAR '25
44.08%
JUN '25
44.08%

Concord Biotech FAQs

As of 08-2025, the promoter shareholding in Concord Biotech stands at 44.08% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Concord Biotech is 9.1% and 0.76% respectively.

The retail shareholding of the Concord Biotech is 37.96%.

Changes in shareholding patterns of Concord Biotech can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Concord Biotech are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.